Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AJANTA PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
AJANTA PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,426314-   
Low Rs1,062226-   
Sales per share (Unadj.) Rs297.293.4-  
Earnings per share (Unadj.) Rs46.7-23.5-  
Cash flow per share (Unadj.) Rs57.1-19.5-  
Dividends per share (Unadj.) Rs7.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs269.173.3-  
Shares outstanding (eoy) m125.91168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.22.9 144.6%   
Avg P/E ratio x26.6-11.5 -232.0%  
P/CF ratio (eoy) x21.8-13.9 -157.3%  
Price / Book Value ratio x4.63.7 125.4%  
Dividend payout %15.00-   
Avg Mkt Cap Rs m156,63845,603 343.5%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m7,8512,862 274.3%   
Avg. sales/employee Rs Th03,671.4-  
Avg. wages/employee Rs Th0666.7-  
Avg. net profit/employee Rs Th0-925.1-  
INCOME DATA
Net Sales Rs m37,42615,761 237.5%  
Other income Rs m986110 893.7%   
Total revenues Rs m38,41315,872 242.0%   
Gross profit Rs m7,833-2,731 -286.8%  
Depreciation Rs m1,308680 192.3%   
Interest Rs m58427 13.7%   
Profit before tax Rs m7,453-3,728 -199.9%   
Minority Interest Rs m0-10 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,573233 675.1%   
Profit after tax Rs m5,880-3,971 -148.1%  
Gross profit margin %20.9-17.3 -120.8%  
Effective tax rate %21.1-6.2 -337.7%   
Net profit margin %15.7-25.2 -62.3%  
BALANCE SHEET DATA
Current assets Rs m28,25211,544 244.7%   
Current liabilities Rs m11,3936,495 175.4%   
Net working cap to sales %45.032.0 140.6%  
Current ratio x2.51.8 139.5%  
Inventory Days Days66111 59.4%  
Debtors Days Days10124 8.3%  
Net fixed assets Rs m18,7076,729 278.0%   
Share capital Rs m25373 345.3%   
"Free" reserves Rs m33,6240-   
Net worth Rs m33,87712,371 273.8%   
Long term debt Rs m134,347 0.3%   
Total assets Rs m47,04723,369 201.3%  
Interest coverage x128.6-7.7 -1,663.3%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x0.80.7 118.0%   
Return on assets %12.6-15.2 -83.2%  
Return on equity %17.4-32.1 -54.1%  
Return on capital %22.2-19.8 -111.9%  
Exports to sales %59.90-   
Imports to sales %11.50-   
Net fx Rs m18,1270-   
CASH FLOW
From Operations Rs m7,9181,345 588.5%  
From Investments Rs m-5,596-413 1,354.7%  
From Financial Activity Rs m-1,0793,945 -27.3%  
Net Cashflow Rs m1,2434,878 25.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.33 Rs / ZAR

Compare AJANTA PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare AJANTA PHARMA With: AUROBINDO PHARMA  VAISHALI PHARMA   SAROJA PHARMA INDUSTRIES INDIA LTD.  AARTI DRUGS  CIPLA  



Today's Market

Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9% Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9%(10:30 am)

Asian stocks fell on Thursday as disappointing earnings forecasts from Facebook parent Meta Platforms hammered tech shares, while the yen's slump past 155 per dollar.